open access

https://hdl.handle.net/2115/70783

Comprehensive review of cell therapy for central nervous system disease in China

日本語

China

2018-05-01

The Hokkaido Medical Society

The Hokkaido journal of medical science

93(1)

13-20

A recent breakthrough in cell therapy is expected to reverse the neurological sequelae of stroke, spinal cord injury, traumatic brain injury and so forth. In fact, various clinical trials concerning cell therapy for central nervous system (CNS) disease have been reported all over the world. Although some pioneer studies were conducted in China, accurate information was not always conveyed to Japan due to the language barrier. In our present article, we reported our systematic review of the scientific papers and the protocols about clinical trials concerning cell therapy for CNS disease in China. Moreover, we reported the regulatory framework for the stem cell research in China. It is noteworthy that we referred to not only English-based databases, but also Chinese-based databases. In conclusion, though some problems remain in China, we expect the acceleration of cell therapy for CNS disease in the future because of the new regulatory framework.

学術雑誌論文

Version of Record

0367-6102